Recruiting Depression Studies in Ann Arbor
Sequential Multiple Assignment Randomized Trial for Bipolar Depression
This is a sequential multiple assignment randomized trial for adults (ages \> 18) with a bipolar disorder type 1 diagnosis currently experiencing a depressive episode. It is a randomized pragmatic tri...
PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence Study
The purpose of this study is to compare the relative effectiveness, acceptability, and side effects of ketamine delivered through an IV (a drip into the arm) which is not currently FDA approved for us...
About Depression Clinical Trials in Ann Arbor
Depression (major depressive disorder) is a common and serious mood disorder that negatively affects how you feel, think, and handle daily activities. It affects over 280 million people globally. Treatment includes psychotherapy, antidepressant medications, and brain stimulation therapies.
There are currently 2 depression clinical trials recruiting participants in Ann Arbor, MICHIGAN. These studies are seeking a combined 3,126 participants. Research is being sponsored by Massachusetts General Hospital, Yale University. Clinical trial participation is free and participants receive study-related medical care at no cost.
Depression Clinical Trials in Ann Arbor — FAQ
Are there depression clinical trials in Ann Arbor?
Yes, there are 2 depression clinical trials currently recruiting in Ann Arbor, MICHIGAN. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Ann Arbor?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Ann Arbor research site will contact you about next steps.
Are clinical trials in Ann Arbor free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Ann Arbor studies also compensate for your time and travel.
What depression treatments are being tested?
The 2 active trials in Ann Arbor are testing new therapies including novel drugs, biologics, and treatment approaches for depression.
Data updated March 2, 2026 from ClinicalTrials.gov